CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica
Abstract Background Neuromyelitis optica spectrum disorder (herein called NMO) is an inflammatory demyelinating disease that can be initiated by binding of immunoglobulin G autoantibodies (AQP4-IgG) to aquaporin-4 on astrocytes, causing complement-dependent cytotoxicity (CDC) and downstream inflamma...
Main Authors: | Lukmanee Tradtrantip, Tianjiao Duan, Michael R. Yeaman, Alan S. Verkman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12974-019-1448-x |
Similar Items
-
Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
by: Tianjiao Duan, et al.
Published: (2018-10-01) -
Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity
by: Tianjiao Duan, et al.
Published: (2019-07-01) -
Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder
by: Lukmanee Tradtrantip, et al.
Published: (2021-11-01) -
Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G
by: Xiaoming Yao, et al.
Published: (2017-07-01) -
Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G
by: Christian M. Felix, et al.
Published: (2016-10-01)